| 000 | 01541 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513111420.0 | ||
| 264 | 0 | _c19970224 | |
| 008 | 199702s 0 0 eng d | ||
| 022 | _a0145-2126 | ||
| 024 | 7 |
_a10.1016/s0145-2126(96)00071-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSackmann-Muriel, F | |
| 245 | 0 | 0 |
_aResults of treatment with an intensive induction regimen using idarubicin in combination with cytarabine and etoposide in children with acute myeloblastic leukemia. _h[electronic resource] |
| 260 |
_bLeukemia research _c |
||
| 300 |
_a973-81 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
| 650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIdarubicin _xadministration & dosage |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aLeukemia, Myeloid _xdrug therapy |
| 650 | 0 | 4 | _aLife Tables |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aZubizarreta, P | |
| 700 | 1 | _aFelice, M S | |
| 700 | 1 | _aChantada, G | |
| 700 | 1 | _aCygler, A M | |
| 700 | 1 | _aGallego, M | |
| 700 | 1 | _aRossi, J | |
| 773 | 0 |
_tLeukemia research _gvol. 20 _gno. 11-12 _gp. 973-81 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0145-2126(96)00071-9 _zAvailable from publisher's website |
| 999 |
_c9000185 _d9000185 |
||